{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.100A>G",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "G",
            "position": "100"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "V",
            "position": "34"
          },
          "Description in input context": "c.100A>G (p.L34V)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0025789"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line and patient-derived material",
        "Material Name": "U-87MG and LN229 glioblastoma cell lines, human astrocytes",
        "Description": "Glioblastoma cell lines U-87MG and LN229 were used along with human astrocytes derived from patients with Parkinson's disease."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.100A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were significantly reduced in cells expressing the c.100A>G variant compared to wild-type controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparisons between groups, and ANOVA for multiple group comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels greater than 80% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels less than 50% of wild-type controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}